泛耐药鲍氏不动杆菌感染的治疗与控制进展

被引：25

作者：

刘方 ^{[1
]}

武迎宏 ^{[2
]}

安友仲 ^{[1
]}

机构：

[1] 北京大学人民医院外科重症加强治疗病房

[2] 北京大学人民医院医院感染管理科

来源：

中华医院感染学杂志 | 2012年 / 22卷 / 04期

关键词：

泛耐药鲍氏不动杆菌; 耐药机制; 治疗进展; 预防控制措施;

D O I：

暂无

中图分类号：

R516 [杆菌传染病];

学科分类号：

100401 ;

摘要：

<正>鲍氏不动杆菌是革兰阴性杆菌,是抗酸不动杆菌种属,目前成为世界范围医院感染的重要致病菌,它具有多种耐药机制,并出现耐药菌株[1],导致临床治疗困惑。美国疾病控制预防中心(CDC)统计,>300所美国医院的监测结果显示[2],抗酸杆菌如鲍氏不动杆菌对碳青霉烯类抗菌药物的耐药率从1995年的9.0%上升至2005年的40.0%。1996-2003年北京协和医院分离的鲍氏不动杆菌对于亚胺培南的耐药率<5.0%,而2004年在ICU患者分离出鲍氏不动杆菌

引用

页码：877 / 880

页数：4

共 8 条

[1] 不动杆菌属多重耐药及泛耐药的分子机制研究 [J].

王辉 ;

孙宏莉 ;

宁永忠 ;

杨启文 ;

陈民钧 ;

朱元珏 ;

徐英春 ;

谢秀丽 .

中华医学杂志, 2006, (01) :17-22

[2]

Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: A 38-month report[J] . Carlo La Forgia,John Franke,Donna M. Hacek,Richard B. Thomson,Ari Robicsek,Lance R. Peterson.AJIC: American Journal of Infection Control . 2010 (4)

[3]

Minocycline—an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus （MRSA） and Acinetobacter baumannii[J] . Eliahu Bishburg,Kathryn Bishburg.International Journal of Antimicrobial Agents . 2009 (5)

[4] Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens [J].

Poulakou, Garyphallia ;

Kontopidou, Flora V. ;

Paramythiotou, Elisabeth ;

Kompoti, Maria ;

Katsiari, Maria ;

Mainas, Efstratios ;

Nicolaou, Chara ;

Yphantis, Dimitrios ;

Antoniadou, Anastasia ;

Trikka-Graphakos, Eleftheria ;

Roussou, Zoi ;

Clouva, Phyllis ;

Maguina, Nina ;

Kanellakopoulou, Kyriaki ;

Armaganidis, Apostolos ;

Giamarellou, Helen .

JOURNAL OF INFECTION, 2009, 58 (04) :273-284

[5]

Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases[J] . Marie-Francoise Tripodi,Emanuele Durante-Mangoni,Rosaria Fortunato,Riccardo Utili,Raffaele Zarrilli.International Journal of Antimicrobial Agents . 2007 (6)

[6]

Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials[J] . Sofia K Kasiakou,George J Sermaides,Argyris Michalopoulos,Elpidoforos S Soteriades,Matthew E Falagas.The Lancet Infectious Diseases . 2005 (9)

[7]

Metallo-β-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: Continued prevalence of VIM-producing pseudomonas spp. and increase of IMP-producing Acinetobacter spp[J] . Kyungwon Lee,Gyoung Yim Ha,Bo-Moon Shin,Jin Ju Kim,Jung Oak Kang,Sook Jin Jang,Dongeun Yong,Yunsop Chong.Diagnostic Microbiology ＆ Infectious Disease . 2004 (1)

[8]

A phase 3. open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae. Vasilev K,Reshedko G,Orasan R. et al. Journal of Antimicrobial Chemotherapy . 2008

← 1 →